Stock Chat

Join Stock Chat and Discuss this DD Report

We are excited to present Affymax, Inc. (OTC: AFFY).

Full DD Report for AFFY

Recent News from (OTC: AFFY)

NIPT Poised For Average Risk Inflection Point
Background Non-Invasive Prenatal Tests " NIPT " have been adopted rapidly since the launch in 2011 by Sequenom (NASDAQ: SQNM ) in the U.S. and BGI in China. Verinata, Ariosa, Natera (NASDAQ: NTRA ) and Berry Genomics launched competitive tests in 2012-2013. These companies represent the ...
Source: SeekingAlpha
Date: February, 15 2016 13:20
Biotech Weekly: Reviewing The
Welcome to this week's edition of Biotech Weekly! While biotech has had a very tumultuous last few weeks, the indexes had a good week with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) rising 4.0% and the S&P Biotech ETF (NYSEARCA: XBI ) gaining 5.4% bringing the IBB to a 16.3% YTD...
Source: SeekingAlpha
Date: September, 01 2015 08:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report.

About Affymax, Inc. (OTC: AFFY)

Logo for Affymax, Inc. (OTC: AFFY)

Not available


Contact Information



Current Management

  • Richard M. Brenner / CEO
  • J. Weston Rose / President
  • Mark Thompson / CFO
  • Lisa Maxson / IR

Current Share Structure

  • Market Cap: $1,787,762 - 03/09/2018
  • Authorized: 100,000,000 - 03/08/2018
  • Issue and Outstanding: 74,490,095 - 03/08/2018


Daily Technical Chart for (OTC: AFFY)

Daily Technical Chart for (OTC: AFFY)

Stay tuned for daily updates and more on (OTC: AFFY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AFFY)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

Monsta Trader



Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AFFY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $0 from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AFFY and does not buy, sell, or trade any shares of AFFY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer:



Release this Report to Investors

Via Email

Via Text


If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us